Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,035 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pathophysiology of irritable bowel syndrome
Holtmann GJ, et al. Lancet Gastroenterol Hepatol 2016 - Review. Among authors: Talley NJ. PMID 28404070
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors
Scheiman JM, et al. Am J Gastroenterol 2006 - Clinical Trial. Among authors: Talley NJ. PMID 16494585
Pooled ulcer rates for patients using COX-2 inhibitors (n = 400) were 16.5% on placebo, 0.9% on esomeprazole 20 mg (p < 0.001) and 4.1% on esomeprazole 40 mg (p= 0.002). ...

Pooled ulcer rates for patients using COX-2 inhibitors (n = 400) were 16.5% on placebo, 0.9% on esomeprazole 20 mg (p < 0.001) and

1,035 results
Jump to page
Feedback